Clinical Laserthermia Systems
5.228 SEK -1.78%1 investor is following this company
Clinical Laserthermia Systems is a company active in medical technology. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as malignant melanoma, as well as cancer in the lungs, liver, and pancreas. The company was founded in 2006 and is headquartered in Lund.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
CLS B
Daily low / high price
5.15 / 5.5
SEK
Market cap
72.83M SEK
Turnover
165.65K SEK
Volume
32K
Financial calendar
Interim report
2024-08-23
Interim report
2024-11-15
Annual report
2025-02-21
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 6.8 % | 6.8 % |
Nordnet Pensionsförsäkring | 6.7 % | 6.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
CLS meddelar sista dag för handel med BTU och första dag för handel med teckningsoptioner av serie TO 7
Redeye: CLS - Rights issue outcome and focus on neurosurgery
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools